Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.

Mihailidou C; Papakotoulas P; Papavassiliou AG; Karamouzis MV

doi:10.18632/oncotarget.28601

← 뒤로

Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.

Oncotarget 2024 Vol.15() p. 461

Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Mihailidou C, Papakotoulas P, et al. (2024). Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.. Oncotarget, 15, 461. https://doi.org/10.18632/oncotarget.28601

MLA Mihailidou C, et al.. "Retraction: Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.." Oncotarget, vol. 15, 2024, pp. 461.

PMID 38985135

DOI 10.18632/oncotarget.28601

MeSH Terms

Ciclopirox; Pancreatic Neoplasms; Humans; Deoxycytidine; Gemcitabine; Pyridones; Antifungal Agents; Animals; Mice